{"rows":[{"id":5156,"title":"1.13 Microdosing of Hallucinogens Among College Students: Frequency, Correlates, and Consequences","authors":"Nicole Fossos-Wong, Ha-Yoon Lee, Kathryn B. Vincent, Devon Alisa Abdallah, Krista S. Dashtestani, M. Dolores Cimini, Karen L. Sokolowski, Geetha Subramaniam, Irene M. Geisner","journal":"Journal of the American Academy of Child & Adolescent Psychiatry","publication_date":"2018-09-30","publication_year":2018,"doi":"10.1016/j.jaac.2018.09.029","pubmed_id":null,"openalex_id":"https://openalex.org/W2897634901","source_url":"https://doi.org/10.1016/j.jaac.2018.09.029","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology,Microdosing","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:01","last_checked":"2026-07-04 06:52:01","bibtex":null,"source_record_id":"DOI:10.1016/j.jaac.2018.09.029","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.jaac.2018.09.029","source_url":"https://doi.org/10.1016/j.jaac.2018.09.029","doi":"10.1016/j.jaac.2018.09.029","pmid":"","publication_date":"2018-09-30","importer_version":"2.1.3","text_redistributed":false}},{"id":5057,"title":"6.3 CURRENT RESEARCH ON PSILOCYBIN TREATMENT ON END-OF-LIFE ANXIETY AND MDMA TREATMENT OF SOCIAL ANXIETY IN AUTISM SPECTRUM DISORDER","authors":"Charles S. Grob","journal":"Journal of the American Academy of Child & Adolescent Psychiatry","publication_date":"2021-10-01","publication_year":2021,"doi":"10.1016/j.jaac.2021.07.053","pubmed_id":null,"openalex_id":"https://openalex.org/W3206624536","source_url":"https://doi.org/10.1016/j.jaac.2021.07.053","substance_tags":"psilocybin","topic_tags":"Anxiety,End-of-Life Distress,Randomized Controlled Trial","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:59","last_checked":"2026-08-09 08:25:44","bibtex":null,"source_record_id":"DOI:10.1016/j.jaac.2021.07.053","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.jaac.2021.07.053","source_url":"https://doi.org/10.1016/j.jaac.2021.07.053","doi":"10.1016/j.jaac.2021.07.053","pmid":"","publication_date":"2021-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5056,"title":"6.2 OVERVIEW OF PSYCHEDELIC COMPOUNDS AND THEIR USE IN TREATMENT","authors":"Matt T. Keener","journal":"Journal of the American Academy of Child & Adolescent Psychiatry","publication_date":"2021-09-30","publication_year":2021,"doi":"10.1016/j.jaac.2021.07.052","pubmed_id":null,"openalex_id":"https://openalex.org/W3205171128","source_url":"https://doi.org/10.1016/j.jaac.2021.07.052","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:59","last_checked":"2026-07-04 06:51:59","bibtex":null,"source_record_id":"DOI:10.1016/j.jaac.2021.07.052","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.jaac.2021.07.052","source_url":"https://doi.org/10.1016/j.jaac.2021.07.052","doi":"10.1016/j.jaac.2021.07.052","pmid":"","publication_date":"2021-09-30","importer_version":"2.1.3","text_redistributed":false}},{"id":4921,"title":"THE RENAISSANCE OF PSYCHEDELICS IN PSYCHIATRY: EVIDENCE, ETHICS, AND POTENTIAL IN MENTAL HEALTH TREATMENT FOR ADOLESCENTS","authors":"Carol Vidal, Kevin M. Gray","journal":"Journal of the American Academy of Child & Adolescent Psychiatry","publication_date":"2022-09-30","publication_year":2022,"doi":"10.1016/j.jaac.2022.07.661","pubmed_id":null,"openalex_id":"https://openalex.org/W4304787309","source_url":"https://doi.org/10.1016/j.jaac.2022.07.661","substance_tags":"psilocybin","topic_tags":"Adolescents","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:56","last_checked":"2026-07-04 06:51:56","bibtex":null,"source_record_id":"DOI:10.1016/j.jaac.2022.07.661","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.jaac.2022.07.661","source_url":"https://doi.org/10.1016/j.jaac.2022.07.661","doi":"10.1016/j.jaac.2022.07.661","pmid":"","publication_date":"2022-09-30","importer_version":"2.1.3","text_redistributed":false}},{"id":4920,"title":"19.3 Psilocybin-Assisted Therapy for MDD: Current Evidence and Clinical Considerations","authors":"Natalie Gukasyan","journal":"Journal of the American Academy of Child & Adolescent Psychiatry","publication_date":"2022-10-01","publication_year":2022,"doi":"10.1016/j.jaac.2022.07.664","pubmed_id":null,"openalex_id":"https://openalex.org/W4304633208","source_url":"https://doi.org/10.1016/j.jaac.2022.07.664","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Receptor Pharmacology,Randomized Controlled Trial","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:56","last_checked":"2026-08-09 08:25:40","bibtex":null,"source_record_id":"DOI:10.1016/j.jaac.2022.07.664","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.jaac.2022.07.664","source_url":"https://doi.org/10.1016/j.jaac.2022.07.664","doi":"10.1016/j.jaac.2022.07.664","pmid":"","publication_date":"2022-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4758,"title":"6.3 Psilocybin Therapy for the Treatment of Young Adults With Anorexia Nervosa: State of the Research","authors":"Amanda E. Downey","journal":"Journal of the American Academy of Child & Adolescent Psychiatry","publication_date":"2023-10-01","publication_year":2023,"doi":"10.1016/j.jaac.2023.07.666","pubmed_id":null,"openalex_id":"https://openalex.org/W4387494383","source_url":"https://doi.org/10.1016/j.jaac.2023.07.666","substance_tags":"psilocybin","topic_tags":"Eating Disorders,Receptor Pharmacology,Clinical Trial","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:45","last_checked":"2026-08-09 08:25:33","bibtex":null,"source_record_id":"DOI:10.1016/j.jaac.2023.07.666","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.jaac.2023.07.666","source_url":"https://doi.org/10.1016/j.jaac.2023.07.666","doi":"10.1016/j.jaac.2023.07.666","pmid":"","publication_date":"2023-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4757,"title":"Psychedelics as Therapeutics: Research Advances and Implications for Practice","authors":"Kevin M. Gray, Paul E. Croarkin","journal":"Journal of the American Academy of Child & Adolescent Psychiatry","publication_date":"2023-09-30","publication_year":2023,"doi":"10.1016/j.jaac.2023.07.1001","pubmed_id":null,"openalex_id":"https://openalex.org/W4387492993","source_url":"https://doi.org/10.1016/j.jaac.2023.07.1001","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:45","last_checked":"2026-07-04 06:34:45","bibtex":null,"source_record_id":"DOI:10.1016/j.jaac.2023.07.1001","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.jaac.2023.07.1001","source_url":"https://doi.org/10.1016/j.jaac.2023.07.1001","doi":"10.1016/j.jaac.2023.07.1001","pmid":"","publication_date":"2023-09-30","importer_version":"2.1.3","text_redistributed":false}}],"total":7,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Journal of the American Academy of Child & Adolescent Psychiatry","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}